Literature DB >> 12229260

Action of carriers on Carbamazepine dissolution.

Mariarosa Moneghini1, Dario Voinovich, Beatrice Perissutti, Francesco Princivalle.   

Abstract

It is well known that carriers can affect the dissolution of poorly soluble drugs. In this study, our aim was to investigate the dissolution enhancement of carbamazepine solid dispersed or mixed at different loading ratios in crospovidone, polyvinylpyrrolidone, and sodium starch glycolate. The physical state of the drug and the drug-polymer interactions in the solid state were investigated using differential scanning calorimetry (DSC) and x-ray diffraction analysis (XRD). Through the solubilization kinetics and dissolution rates studies, the in vitro drug availability of the systems was evaluated. An improved in vitro dissolution of the drug was obtained in all the binary systems that increased as the polymer content increased.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12229260     DOI: 10.1081/pdt-120005725

Source DB:  PubMed          Journal:  Pharm Dev Technol        ISSN: 1083-7450            Impact factor:   3.133


  4 in total

1.  Impairment of the in vitro release of carbamazepine from tablets.

Authors:  Alija Uzunović; Edina Vranić; Seherzada Hadzidedić
Journal:  Bosn J Basic Med Sci       Date:  2010-08       Impact factor: 3.363

2.  Effect of hydrophilic swellable polymers on dissolution enhancement of carbamazepine solid dispersions studied using response surface methodology.

Authors:  Yogesh Rane; Rajshree Mashru; Mayur Sankalia; Jolly Sankalia
Journal:  AAPS PharmSciTech       Date:  2007-04-06       Impact factor: 3.246

3.  Evaluation of Influence of Various Polymers on Dissolution and Phase Behavior of Carbamazepine-Succinic Acid Cocrystal in Matrix Tablets.

Authors:  Majeed Ullah; Hanif Ullah; Ghulam Murtaza; Qaisar Mahmood; Izhar Hussain
Journal:  Biomed Res Int       Date:  2015-08-24       Impact factor: 3.411

4.  Fast disintegrating crystalline solid dispersions of simvastatin for incorporation into orodispersible tablets.

Authors:  Ritesh M Pabari; Asha Jamil; John G Kelly; Zebunnissa Ramtoola
Journal:  Int J Pharm Investig       Date:  2014-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.